Cargando…

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System

Excessive secretion of triglyceride-rich very low-density lipoproteins (VLDL-TG) contributes to diabetic dyslipidemia. Earlier studies have indicated a possible role for the hypothalamus and autonomic nervous system in the regulation of VLDL-TG. In the current study, we investigated whether the auto...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruinstroop, Eveline, Pei, Lei, Ackermans, Mariëtte T., Foppen, Ewout, Borgers, Anke J., Kwakkel, Joan, Alkemade, Anneke, Fliers, Eric, Kalsbeek, Andries
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331766/
https://www.ncbi.nlm.nih.gov/pubmed/22461566
http://dx.doi.org/10.2337/db11-1142
_version_ 1782230140357443584
author Bruinstroop, Eveline
Pei, Lei
Ackermans, Mariëtte T.
Foppen, Ewout
Borgers, Anke J.
Kwakkel, Joan
Alkemade, Anneke
Fliers, Eric
Kalsbeek, Andries
author_facet Bruinstroop, Eveline
Pei, Lei
Ackermans, Mariëtte T.
Foppen, Ewout
Borgers, Anke J.
Kwakkel, Joan
Alkemade, Anneke
Fliers, Eric
Kalsbeek, Andries
author_sort Bruinstroop, Eveline
collection PubMed
description Excessive secretion of triglyceride-rich very low-density lipoproteins (VLDL-TG) contributes to diabetic dyslipidemia. Earlier studies have indicated a possible role for the hypothalamus and autonomic nervous system in the regulation of VLDL-TG. In the current study, we investigated whether the autonomic nervous system and hypothalamic neuropeptide Y (NPY) release during fasting regulates hepatic VLDL-TG secretion. We report that, in fasted rats, an intact hypothalamic arcuate nucleus and hepatic sympathetic innervation are necessary to maintain VLDL-TG secretion. Furthermore, the hepatic sympathetic innervation is necessary to mediate the stimulatory effect of intracerebroventricular administration of NPY on VLDL-TG secretion. Since the intracerebroventricular administration of NPY increases VLDL-TG secretion by the liver without affecting lipolysis, its effect on lipid metabolism appears to be selective to the liver. Together, our findings indicate that the increased release of NPY during fasting stimulates the sympathetic nervous system to maintain VLDL-TG secretion at a postprandial level.
format Online
Article
Text
id pubmed-3331766
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-33317662013-05-01 Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System Bruinstroop, Eveline Pei, Lei Ackermans, Mariëtte T. Foppen, Ewout Borgers, Anke J. Kwakkel, Joan Alkemade, Anneke Fliers, Eric Kalsbeek, Andries Diabetes Metabolism Excessive secretion of triglyceride-rich very low-density lipoproteins (VLDL-TG) contributes to diabetic dyslipidemia. Earlier studies have indicated a possible role for the hypothalamus and autonomic nervous system in the regulation of VLDL-TG. In the current study, we investigated whether the autonomic nervous system and hypothalamic neuropeptide Y (NPY) release during fasting regulates hepatic VLDL-TG secretion. We report that, in fasted rats, an intact hypothalamic arcuate nucleus and hepatic sympathetic innervation are necessary to maintain VLDL-TG secretion. Furthermore, the hepatic sympathetic innervation is necessary to mediate the stimulatory effect of intracerebroventricular administration of NPY on VLDL-TG secretion. Since the intracerebroventricular administration of NPY increases VLDL-TG secretion by the liver without affecting lipolysis, its effect on lipid metabolism appears to be selective to the liver. Together, our findings indicate that the increased release of NPY during fasting stimulates the sympathetic nervous system to maintain VLDL-TG secretion at a postprandial level. American Diabetes Association 2012-05 2012-04-13 /pmc/articles/PMC3331766/ /pubmed/22461566 http://dx.doi.org/10.2337/db11-1142 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Metabolism
Bruinstroop, Eveline
Pei, Lei
Ackermans, Mariëtte T.
Foppen, Ewout
Borgers, Anke J.
Kwakkel, Joan
Alkemade, Anneke
Fliers, Eric
Kalsbeek, Andries
Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
title Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
title_full Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
title_fullStr Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
title_full_unstemmed Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
title_short Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
title_sort hypothalamic neuropeptide y (npy) controls hepatic vldl-triglyceride secretion in rats via the sympathetic nervous system
topic Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331766/
https://www.ncbi.nlm.nih.gov/pubmed/22461566
http://dx.doi.org/10.2337/db11-1142
work_keys_str_mv AT bruinstroopeveline hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem
AT peilei hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem
AT ackermansmariettet hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem
AT foppenewout hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem
AT borgersankej hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem
AT kwakkeljoan hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem
AT alkemadeanneke hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem
AT flierseric hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem
AT kalsbeekandries hypothalamicneuropeptideynpycontrolshepaticvldltriglyceridesecretioninratsviathesympatheticnervoussystem